Senzime www.senzime.vom has signed exclusive agreements for the commercialization of the TetraGraph system with EIKOS Care Medical www.eikoscare.com, the exclusive distributor in Spain. In addition, Geranswers Medical Solutions www.geranswers.com will be the exclusive distributor in Portugal. Both EIKOS Care Medical and Geranswers Medical Solutions have extensive experience in the medical device industry in Spain and Portugal with a focus on novel technologies.
TetraGraph is a user friendly system for monitoring patients undergoing general anesthesia with muscle relaxant drugs. The system makes it possible to determine the correct dose of muscle relaxants and helps the clinician determine when the patient is sufficiently recovered to sustain spontaneous breathing. The system consists of a portable, hand-held patient monitoring unit and non-invasive disposable sensors.
Lena Soderstrom, CEO Senzime said, “EIKOS Care Medical and Geranswers Medical Solutions are partners with complementary product portfolios and extensive connections in the anesthesia field within their home markets.”
Other Senzime technologies include bedside systems enabling automated and continuous monitoring of life critical substances such as glucose and lactate in both blood and tissues as well as systems to monitor patients’ neuromuscular function.
Senzime presently has distribution agreements for TetraGraph in the UK, Ireland, Switzerland, Australia, and New Zealand along with licensing agreements in Japan. Senzime growing markets in Europe and the U.S are valued in excess of SEK 20 billion. Discussions are ongoing with distributors for additional markets and additional agreements are expected to be signed during 2018.
For further information, email Lena Soderstrom, at lena.soderstrom@senzime.com